Land: Australien
Språk: engelska
Källa: Department of Health (Therapeutic Goods Administration)
ferrous sulfate, Quantity: 325 mg; ascorbic acid, Quantity: 500 mg
Ferromedica Holdings Pty Ltd
Tablet, modified release
Excipient Ingredients: magnesium stearate; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000; lecithin; iron oxide red; macrogol 4000
Oral
30
(S2) Pharmacy Medicine
For the prevention and treatment of iron deficiency anaemia; iron and vitamin C supplementation which may help relieve fatigue, where dietary intake of both nutrients is inadequate.
Visual Identification: Reddish brown film-coated oval shaped tablet with break bar; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Registered
2021-10-21